Cargando…
Biosimilars in rare diseases : a focus on paroxysmal nocturnal hemoglobinuria
Biologics, a class of medicines grown in and purified from genetically engineered cell cultures, have transformed the management of many cancers and rare diseases, such as paroxysmal nocturnal hemoglobinuria. As prescription drug spending has increased and exclusivity periods have expired, manufactu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153517/ https://www.ncbi.nlm.nih.gov/pubmed/36519328 http://dx.doi.org/10.3324/haematol.2022.281562 |